Axon Enterprise, Inc $AXON Shares Acquired by NBH Bank

NBH Bank grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 5,493.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,908 shares of the biotechnology company’s stock after purchasing an additional 10,713 shares during the period. Axon Enterprise makes up 1.8% of NBH Bank’s investment portfolio, making the stock its 13th largest position. NBH Bank’s holdings in Axon Enterprise were worth $4,609,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. State Street Corp lifted its position in Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after buying an additional 209,879,882 shares during the last quarter. Envestnet Asset Management Inc. boosted its stake in Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock worth $7,400,094,000 after buying an additional 13,127,348 shares during the period. Robeco Institutional Asset Management B.V. increased its position in shares of Axon Enterprise by 391,214.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock valued at $2,952,943,000 after acquiring an additional 6,987,098 shares during the last quarter. Assenagon Asset Management S.A. increased its position in shares of Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock valued at $1,802,719,000 after acquiring an additional 4,183,302 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of Axon Enterprise by 8,432.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after acquiring an additional 3,496,493 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Axon Enterprise

In related news, insider Isaiah Fields sold 1,017 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 in the last 90 days. Corporate insiders own 4.20% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are a few of the latest headlines about AXON:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $315.42 on Thursday. The stock has a market capitalization of $25.68 billion, a price-to-earnings ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The business has a 50-day moving average of $426.24 and a 200 day moving average of $470.65. Axon Enterprise, Inc has a 12 month low of $291.45 and a 12 month high of $665.07.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The business had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The firm’s revenue for the quarter was up 27.8% on a year-over-year basis. During the same quarter last year, the company earned $1.17 earnings per share. As a group, sell-side analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC reduced their price target on shares of Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Northland Securities set a $540.00 price objective on shares of Axon Enterprise in a research report on Friday, November 6th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 target price for the company. in a report on Friday, November 6th. Northcoast Research lifted their target price on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Finally, Royal Bank Of Canada cut their target price on Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating on the stock in a research report on Friday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $612.18.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.